Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841996 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
A Phase 1 study of Onychomycosis, sponsored by Meiji Seika Pharma Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT01841996: Completed Phase 1 study of Onychomycosis, sponsored by Meiji Seika Pharma Co..
NCT01841996 is a Phase 1 study of Onychomycosis that has completed, run by Meiji Seika Pharma Co.. The registered enrollment target is 24 participants, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01841996, a Phase 1 study of Onychomycosis, has completed, sponsored by Meiji Seika Pharma Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study. The purpose is to determine the safety, tolerability, systemic exposure and pharmacokinetics of ME1111 after repeated daily topical application of ME1111 in a maximal use setting in adults with distal subungual onychomycosis of the toenails.
Conditions Studied
Interventions
- DRUG Vehicle Solution
- DRUG ME1111 solution
Study Locations (2)
Texas
- - Austin
- - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-03 |
| Phase | Phase 1 |
What the finished NCT01841996 record still lists
NCT01841996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 2 interventions - of which Vehicle Solution is the first listed.
NCT01841996 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01841996 about?
NCT01841996 is a clinical study titled "Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients". This study is Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study. The purpose is to determine the safety, tolerability, systemic exposure and pharmacokinetics of ME1111 after repeated daily topical application of ME1111 in a maximal use setting in adults with distal subungual onychom...
What is the current status of trial NCT01841996?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2013-03.
What conditions does trial NCT01841996 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT01841996?
The interventions under investigation include: Vehicle Solution (DRUG), ME1111 solution (DRUG).
Who is sponsoring clinical trial NCT01841996?
This trial is sponsored by Meiji Seika Pharma Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01841996 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01841996's enrollment target sits among peer trials
24 11th of 11 higher than 1 of 11 other Onychomycosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Onychomycosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis
COMPLETED · Phase 1
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
-
Spread of Dermatophytes Among Families
COMPLETED
-
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia